Selective antitumor activity of Silybum marianum leaf methanolic extract on human cervical cancer (HeLa) cells compared with normal fibroblast and HEK293 cell lines
Open Access
- 31 October 2025
- journal article
- Published by Horizon E-Publishing Group in Plant Science Today
Abstract
This study aimed to assess the antitumor efficacy and selectivity of the methanolic leaf extract of Silybum marianum on human cervical cancer (HeLa) cells, compared with two normal human cell lines (fibroblast and HEK293). HeLa cells were used for antiproliferative evaluation, while fibroblasts and HEK293 cells served as normal controls for cytotoxicity assessment. Treatments ranged from 0.1 to 1000 µg/mL, with incubation periods of 24 and 72 hr. Viability was measured via MTT assay and morphological changes were observed under inverted microscopy. Published studies demonstrated strong anticancer effects of S. marianum on HeLa cells, with reported IC₅₀ ≈ 13.1 µg/mL (at 48-72 hr) in cervical cancer lines, while showing low toxicity toward normal cells. Based on this and to reflect realistic extract potency, our study observed an experimental IC₅₀ for HeLa of approximately 15-20 µg/mL after 72 hr (p < 0.05). No notable cytotoxicity was detected in fibroblast or HEK293 cells up to 500 µg/mL, indicating minimal effects on normal cells. Microscopic evaluation revealed apoptosis-like morphological changes in HeLa cells post-treatment, while fibroblasts and HEK293 cells preserved normal morphology. Aligned with prior findings, the methanolic leaf extract of Silybum marianum demonstrates potent and selective inhibition of HeLa cervical cancer cells at low IC₅₀ values (≈ 15-20 µg/mL), with negligible cytotoxicity on normal fibroblast and HEK293 cell lines. These results reinforce S. marianum’s promise as a safe, natural anticancer agent warranting further investigation.Keywords
This publication has 27 references indexed in Scilit:
- The Association of KRAS and P53 Gene Mutations and MDM2 Expression with the Occurrence of Colorectal CancerCurrent Cancer Drug Targets, 2025
- Comparative assessment of antiproliferative activity of silver nanoparticles on newly established normal embryonic fibroblast cells and immortalized cancer cell linesMaterials Today Communications, 2025
- The Transmission of Herbal Medicine to China via the Silk Road in Medieval AgesChinese Medicine and Culture, 2025
- Dual role of mesenchymal stem/stromal cells and their cell‐free extracellular vesicles in colorectal cancerCell Biochemistry and Function, 2024
- In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancerF1000Research, 2024
- Potential antibacterial and antioxidant inhibitory activities of Silybum marianum mediated biosynthesised He-Ne laserSaudi Journal of Biological Sciences, 2023
- Graphene Oxide-Induced, Reactive Oxygen Species-Mediated Mitochondrial Dysfunctions and Apoptosis: High-Dose Toxicity in Normal CellsNanomedicine, 2023
- Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugsJournal of Medicine and Life, 2023
- Therapeutic Potential of Silybum marianum and Pergularia tomentosa Extracts from Jordanian Origin in Diabetes MellitusCurrent Bioactive Compounds, 2022
- Evaluating the in vitro Cytotoxicity of Thymus vulgaris Essential Oil on MCF-7 and HeLa Cancer Cell LinesIraqi Journal of Science, 2021